Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/10/2021 06/11/2021 06/14/2021 06/15/2021 06/16/2021 Date
167.08(c) 164.96(c) 165.37(c) 164.49(c) 165.07 Last
6 463 322 7 389 922 4 931 297 5 063 027 281 364 Volume
+0.90% -1.27% +0.25% -0.53% +0.35% Change
More quotes
Financials (USD)
Sales 2021 92 812 M - -
Net income 2021 22 227 M - -
Net Debt 2021 314 M - -
P/E ratio 2021 19,8x
Yield 2021 2,54%
Sales 2022 97 470 M - -
Net income 2022 23 317 M - -
Net cash position 2022 7 133 M - -
P/E ratio 2022 18,2x
Yield 2022 2,68%
Capitalization 433 B 433 B -
EV / Sales 2021 4,67x
EV / Sales 2022 4,37x
Nbr of Employees 134 500
Free-Float 84,3%
More Financials
Company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care,... 
Sector
Pharmaceuticals
Calendar
06/23 | 08:00amSpecial Situation
More about the company
Ratings of Johnson & Johnson
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about JOHNSON & JOHNSON
09:22aEU Says Johnson & Johnson May Not Meet Vaccine Supply Commitment After Jabs C..
MT
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
MT
06/15JOHNSON & JOHNSONá : Aspen to Dispatch 300 000 J&J Vaccines for Teachers
AQ
06/15JOHNSON & JOHNSONá : Donated US vaccines arrive for Mexican border cities
AQ
06/15THE LATEST : Johnson & Johnson shots arrive in Mexico from US
AQ
06/15FEDEXá : Makes its First COVID-19 Vaccine Delivery to Mexico, of 1.35 Million Jo..
MT
06/15FedEx Delivers 1.35 Million J&J Covid-19 Vaccine Doses to Mexico
DJ
06/15JOHNSON & JOHNSONá : COVID-19 Vaccine Wins Emergency Use Approval In Malaysia
MT
06/14THE LATEST : Easing of COVID restrictions delayed in England
AQ
06/14JOHNSON & JOHNSONá : South Africa rejects 2m J&J vaccines due to FDA decision
AQ
06/14Novavax Says COVID-19 Vaccine 90% Effective; Plans to Seek Regulatory Authori..
MT
06/14MODERNAá : Appoints New Chief Medical Officer
MT
06/14MODERNAá : Appoints Chief Medical Officer
MT
06/14Moderna Taps J&J Executive Burton as Medical Chief
DJ
06/14JOHNSON & JOHNSONá : New Phase 3 Study Results Show IMBRUVICA -Based Combination..
AQ
More news
News in other languages on JOHNSON & JOHNSON
08:00aBiontech liefert nach 'Übererfüllung' wieder wie vereinbart
07:31aJohnson & Johnson liefert nach EU-Angaben weniger als geplant
06/14J&Já : les promesses du Darzalex dans le myélome multiple
06/13CORONAVIRUS : le point sur la pandémie dans le monde
06/13Ausgabe digitaler Impfausweise beginnt - Diskussion um Maskenpflicht
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 183,67 $
Last Close Price 164,49 $
Spread / Highest target 24,0%
Spread / Average Target 11,7%
Spread / Lowest Target -3,95%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
PFIZER, INC.7.55%221 613
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582
ELI LILLY AND COMPANY32.39%203 185